Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.
about
A noncoding expansion in EIF4A3 causes Richieri-Costa-Pereira syndrome, a craniofacial disorder associated with limb defectsExpanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALSThe multiple molecular facets of fragile X-associated tremor/ataxia syndromeCGG repeat in the FMR1 gene: size mattersMouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndromeFragile X Syndrome: Scientific Background and Screening Technologies.Rodent models of TDP-43: recent advances.Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.Reproductive tract function and dysfunction in women.Fragile X-Associated Diminished Ovarian Reserve and Primary Ovarian Insufficiency from Molecular Mechanisms to Clinical Manifestations.MicroRNA expression profiling in blood from fragile X-associated tremor/ataxia syndrome patients.RNA-binding proteins in neurodegeneration: mechanisms in aggregate.ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics.Reevaluation of FMR1 Hypermethylation Timing in Fragile X Syndrome.Human DNA Helicase B as a Candidate for Unwinding Secondary CGG Repeat Structures at the Fragile X Mental Retardation Gene.Complexity of the 5' Untranslated Region of EIF4A3, a Critical Factor for Craniofacial and Neural Development.
P2860
Q24315833-F63B483C-CAE4-4853-865F-92BA521A4D4EQ24633692-BCE257F0-B8B7-4D98-BFE0-7DD2E7664B6BQ26852891-1ED62371-1060-402B-B40E-0A5588025AC9Q30464036-ECEE4E12-61E7-4F92-818B-32D10D618826Q34055453-ED6F9404-D02A-4D93-B71E-C2BF6DA35E1EQ36206132-71536368-A13A-4E01-9F58-A237F82408BDQ36731287-FA364CF0-3560-4EC2-9E09-99BD91B9F2DAQ37524454-F59CA3FE-C3E6-4AAD-9223-092F1DFA8DE3Q37580522-08867E15-7AAE-48D7-BE58-937C40B8D7E0Q37879446-DCD3A4F0-C67D-4895-A130-7FF22A3ACE32Q41684295-B0C83487-560A-4822-95DA-5154D8A274A1Q45293759-E5E4D3ED-91CD-41E0-AF0E-5F18F2F81F72Q47569012-31DA41E1-25A8-4AF2-BCF9-B6874A3E4D04Q48621332-ADE8D7FD-093D-4AF0-B157-8F7C4187089FQ50166708-609322CB-FFB7-4F44-9B46-E41E7DB4F9F7Q55234993-B8E0C547-AE99-4C35-BDCE-613CD1844DA1Q55384242-CC52BD60-EE56-41EB-82BE-571A0DE31EF5
P2860
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.
@ast
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.
@en
type
label
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.
@ast
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.
@en
prefLabel
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.
@ast
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.
@en
P2860
P356
P1433
P1476
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.
@en
P2093
David L Nelson
Jocelyn N Galloway
P2860
P356
10.2217/FNL.09.44
P577
2009-11-01T00:00:00Z